Lanqiu Zhang1, Chongyang Qiu2, Lei Yang1, Zhen Zhang2, Qi Zhang1, Botao Wang2, Ximo Wang3. 1. Tianjin Key Laboratory of Acute Abdomen Disease Associated Organ Injury and ITCWM Repair, Institute of Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin, 300100, China. 2. Graduate School, Tianjin Medical University, Tianjin 300070, China. 3. Tianjin Key Laboratory of Acute Abdomen Disease Associated Organ Injury and ITCWM Repair, Institute of Acute Abdominal Diseases, Tianjin Nankai Hospital, Tianjin, 300100, China. Electronic address: wangximonkyy@126.com.
Abstract
AIMS: GPR18, a G protein-coupled receptor (GPCR), is involved in bacterial clearance and survival in microbial sepsis. In this study, we examine GPR18 expression on polymorphonuclear neutrophils (PMNs) of patients with sepsis and to determine the potential association with disease severity and outcomes. MAIN METHODS: We enrolled 81 patients admitted at the intensive care unit (ICU) with the diagnosis of sepsis. PMNs GPR18 expression was measured by flow cytometry at admission. Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation (APACHEII) as well as other biomarker were measured at admission. Cox regression analysis was used to determine the influence of PMNs GPR18 expression on 28-day mortality. KEY FINDINGS: Patients with sepsis had a decreased percentage of PMNs bearing GPR18 in comparison with healthy subjects (P < 0.001). Compared with survivors, non-survivors had lower percentage of GPR18-positive PMNs, but higher SOFA, APACHEIIscores, and WBC count. There were inverse correlations between the percentage of GPR18-positive PMNs and APACHEII, SOFA score and C-recreative protein (CRP). Using Kaplan-Meier analysis, high percentage of PMNs expressing GPR18 (≥43.7%) was associated with a preferable 28-day survival (P = 0.004). High percentage of PMNs expressing GPR18 (≥43.7%) was significantly and independently associated with 28-day mortality, with a hazard ratio of 0.36 (P = 0.37). Moreover, LPS-Toll-like receptor (TLR)4 signaling mediated the GPR18 expression on PMNs. SIGNIFICANCE: These results indicate that decreased percentage GPR18-positive PMNs is associated with increased severity and poorer outcome of sepsis.
AIMS: GPR18, a G protein-coupled receptor (GPCR), is involved in bacterial clearance and survival in microbial sepsis. In this study, we examine GPR18 expression on polymorphonuclear neutrophils (PMNs) of patients with sepsis and to determine the potential association with disease severity and outcomes. MAIN METHODS: We enrolled 81 patients admitted at the intensive care unit (ICU) with the diagnosis of sepsis. PMNs GPR18 expression was measured by flow cytometry at admission. Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation (APACHEII) as well as other biomarker were measured at admission. Cox regression analysis was used to determine the influence of PMNs GPR18 expression on 28-day mortality. KEY FINDINGS:Patients with sepsis had a decreased percentage of PMNs bearing GPR18 in comparison with healthy subjects (P < 0.001). Compared with survivors, non-survivors had lower percentage of GPR18-positive PMNs, but higher SOFA, APACHEIIscores, and WBC count. There were inverse correlations between the percentage of GPR18-positive PMNs and APACHEII, SOFA score and C-recreative protein (CRP). Using Kaplan-Meier analysis, high percentage of PMNs expressing GPR18 (≥43.7%) was associated with a preferable 28-day survival (P = 0.004). High percentage of PMNs expressing GPR18 (≥43.7%) was significantly and independently associated with 28-day mortality, with a hazard ratio of 0.36 (P = 0.37). Moreover, LPS-Toll-like receptor (TLR)4 signaling mediated the GPR18 expression on PMNs. SIGNIFICANCE: These results indicate that decreased percentage GPR18-positive PMNs is associated with increased severity and poorer outcome of sepsis.
Authors: Alexander M C Böhner; Alice M Jacob; Christoph Heuser; Natascha E Stumpf; Alexander Effland; Zeinab Abdullah; Catherine Meyer-Schwesiger; Sibylle von Vietinghoff; Christian Kurts Journal: J Am Soc Nephrol Date: 2021-06-18 Impact factor: 14.978
Authors: Simon C Dyall; Laurence Balas; Nicolas G Bazan; J Thomas Brenna; Nan Chiang; Felipe da Costa Souza; Jesmond Dalli; Thierry Durand; Jean-Marie Galano; Pamela J Lein; Charles N Serhan; Ameer Y Taha Journal: Prog Lipid Res Date: 2022-05-01 Impact factor: 14.673
Authors: Mark Soave; Leigh A Stoddart; Carl W White; Laura E Kilpatrick; Joëlle Goulding; Stephen J Briddon; Stephen J Hill Journal: FEBS J Date: 2021-02-09 Impact factor: 5.542